ctni antibody Search Results


90
Biosynth Carbosynth ctni
Ctni, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ctni/product/Biosynth Carbosynth
Average 90 stars, based on 1 article reviews
ctni - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

95
Proteintech anti ncx1
Anti Ncx1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ncx1/product/Proteintech
Average 95 stars, based on 1 article reviews
anti ncx1 - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

92
Biorbyt rabbit polyclonal antibody for ctni
Immunofluorescent analysis indicates the expression of NKX2.5 and <t>cTnI</t> (green) in the hearts of rats with MI two and four weeks after PMSCs and HPL + PMSCs injection: ( A , B ): Sample micrographs of NKX2.5 and cTnI in an animal of each group. Quantification of the levels of NKX2.5 + and cTnI+ ( C and E ) and the number of Dil+/NKX2.5 + and Dil+/ cTnI+ ( D and F ) in the study groups. Stem cells stained with Dil dye (red) and nuclei with DAPI (blue). *** P < 0.001 vs. PMSCs 2 weeks; # < P < 0.05, ### P < 0.001 vs. HPL + PMSCs 2 weeks; &&& P < 0.01 vs. PMSCs; $$ P < 0.001, $$$ P < 0.001 vs. HPL + PMSCs. n = 3 in each group.
Rabbit Polyclonal Antibody For Ctni, supplied by Biorbyt, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal antibody for ctni/product/Biorbyt
Average 92 stars, based on 1 article reviews
rabbit polyclonal antibody for ctni - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

93
Proteintech tnni3
a Real-time quantitative polymerase chain reaction (RT-qPCR)-determined levels of the designated mRNAs during human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) differentiation. Levels of indicated genes are shown normalized to RPLP0 levels at each timepoint. Day 0 and 2, n = 9; Day 4, 6, 8, and 15, n = 8. * p < 0.05, *** p < 0.001, **** p < 0.0001 vs Day 0; one-way ANOVA followed by Dunnett’s multiple comparison test. b Representative immunoblots of estrogen-related receptor (ERR) α and γ protein levels during hiPSC-CM differentiation. α-Tubulin was used as a loading control. c Heatmap representing log 2 fold change [ERRα/γ knockout (KO)/wild-type control (WT)] of mRNA levels of genes involved in cardiac structural component, Ca 2+ handling function, and ion transport in two different KO cell lines (KO1, KO6). All changes were significant (Benjamini-Hochberg false discovery rate <0.05) except for SCN5A in KO1 ( p = 0.057). d Representative immunoblots of indicated protein levels in WT Control and ERRα/γ KO hiPSC-CMs. Total protein staining was shown as a loading control. e The mRNA levels of indicated genes determined by RT-qPCR in hiPSC-CMs following the infection of adenovirus expressing GFP or ERRγ (Ad-GFP or Ad-ERRγ). ** p < 0.01, *** p < 0.001, **** p < 0.0001, Ad-ERRγ vs Ad-GFP, two-tailed student’s t-test. PDK4 (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); COX6A2 (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); MDH1 and CKMT2 , (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); <t>TNNI3</t> (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); TNNI1 (Ad-GFP, n = 10 and Ad-ERRγ, n = 11). f The mRNA levels of indicated hiPSC-CM maturation markers determined by RT-qPCR in WT and ERRα/γ KO hiPSC-CMs derived from KO1 and KO6 with ( n = 15) or without ( n = 9) maturation cocktail treatment for 7 days. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, WT vs ERRα/γ KO hiPSC-CMs, two-way ANOVA followed by Tukey’s multiple comparisons test. All graphs in a , e , and f represent the means ± SEM. n denotes independent biological replicates. g Representative immunoblot images to show ACSL1 and TNNI3 protein expression levels in WT and ERRα/γ KO hiPSC-CMs with or without maturation cocktail. Total protein staining was used as a loading control.
Tnni3, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tnni3/product/Proteintech
Average 93 stars, based on 1 article reviews
tnni3 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

95
HyTest ctni antibody plate
a Real-time quantitative polymerase chain reaction (RT-qPCR)-determined levels of the designated mRNAs during human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) differentiation. Levels of indicated genes are shown normalized to RPLP0 levels at each timepoint. Day 0 and 2, n = 9; Day 4, 6, 8, and 15, n = 8. * p < 0.05, *** p < 0.001, **** p < 0.0001 vs Day 0; one-way ANOVA followed by Dunnett’s multiple comparison test. b Representative immunoblots of estrogen-related receptor (ERR) α and γ protein levels during hiPSC-CM differentiation. α-Tubulin was used as a loading control. c Heatmap representing log 2 fold change [ERRα/γ knockout (KO)/wild-type control (WT)] of mRNA levels of genes involved in cardiac structural component, Ca 2+ handling function, and ion transport in two different KO cell lines (KO1, KO6). All changes were significant (Benjamini-Hochberg false discovery rate <0.05) except for SCN5A in KO1 ( p = 0.057). d Representative immunoblots of indicated protein levels in WT Control and ERRα/γ KO hiPSC-CMs. Total protein staining was shown as a loading control. e The mRNA levels of indicated genes determined by RT-qPCR in hiPSC-CMs following the infection of adenovirus expressing GFP or ERRγ (Ad-GFP or Ad-ERRγ). ** p < 0.01, *** p < 0.001, **** p < 0.0001, Ad-ERRγ vs Ad-GFP, two-tailed student’s t-test. PDK4 (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); COX6A2 (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); MDH1 and CKMT2 , (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); <t>TNNI3</t> (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); TNNI1 (Ad-GFP, n = 10 and Ad-ERRγ, n = 11). f The mRNA levels of indicated hiPSC-CM maturation markers determined by RT-qPCR in WT and ERRα/γ KO hiPSC-CMs derived from KO1 and KO6 with ( n = 15) or without ( n = 9) maturation cocktail treatment for 7 days. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, WT vs ERRα/γ KO hiPSC-CMs, two-way ANOVA followed by Tukey’s multiple comparisons test. All graphs in a , e , and f represent the means ± SEM. n denotes independent biological replicates. g Representative immunoblot images to show ACSL1 and TNNI3 protein expression levels in WT and ERRα/γ KO hiPSC-CMs with or without maturation cocktail. Total protein staining was used as a loading control.
Ctni Antibody Plate, supplied by HyTest, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ctni antibody plate/product/HyTest
Average 95 stars, based on 1 article reviews
ctni antibody plate - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

95
HyTest ctni primary antibody 1ab stock solution
a Real-time quantitative polymerase chain reaction (RT-qPCR)-determined levels of the designated mRNAs during human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) differentiation. Levels of indicated genes are shown normalized to RPLP0 levels at each timepoint. Day 0 and 2, n = 9; Day 4, 6, 8, and 15, n = 8. * p < 0.05, *** p < 0.001, **** p < 0.0001 vs Day 0; one-way ANOVA followed by Dunnett’s multiple comparison test. b Representative immunoblots of estrogen-related receptor (ERR) α and γ protein levels during hiPSC-CM differentiation. α-Tubulin was used as a loading control. c Heatmap representing log 2 fold change [ERRα/γ knockout (KO)/wild-type control (WT)] of mRNA levels of genes involved in cardiac structural component, Ca 2+ handling function, and ion transport in two different KO cell lines (KO1, KO6). All changes were significant (Benjamini-Hochberg false discovery rate <0.05) except for SCN5A in KO1 ( p = 0.057). d Representative immunoblots of indicated protein levels in WT Control and ERRα/γ KO hiPSC-CMs. Total protein staining was shown as a loading control. e The mRNA levels of indicated genes determined by RT-qPCR in hiPSC-CMs following the infection of adenovirus expressing GFP or ERRγ (Ad-GFP or Ad-ERRγ). ** p < 0.01, *** p < 0.001, **** p < 0.0001, Ad-ERRγ vs Ad-GFP, two-tailed student’s t-test. PDK4 (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); COX6A2 (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); MDH1 and CKMT2 , (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); <t>TNNI3</t> (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); TNNI1 (Ad-GFP, n = 10 and Ad-ERRγ, n = 11). f The mRNA levels of indicated hiPSC-CM maturation markers determined by RT-qPCR in WT and ERRα/γ KO hiPSC-CMs derived from KO1 and KO6 with ( n = 15) or without ( n = 9) maturation cocktail treatment for 7 days. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, WT vs ERRα/γ KO hiPSC-CMs, two-way ANOVA followed by Tukey’s multiple comparisons test. All graphs in a , e , and f represent the means ± SEM. n denotes independent biological replicates. g Representative immunoblot images to show ACSL1 and TNNI3 protein expression levels in WT and ERRα/γ KO hiPSC-CMs with or without maturation cocktail. Total protein staining was used as a loading control.
Ctni Primary Antibody 1ab Stock Solution, supplied by HyTest, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ctni primary antibody 1ab stock solution/product/HyTest
Average 95 stars, based on 1 article reviews
ctni primary antibody 1ab stock solution - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

90
Merck KGaA cardiac troponin i (ctni) antibody
a Real-time quantitative polymerase chain reaction (RT-qPCR)-determined levels of the designated mRNAs during human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) differentiation. Levels of indicated genes are shown normalized to RPLP0 levels at each timepoint. Day 0 and 2, n = 9; Day 4, 6, 8, and 15, n = 8. * p < 0.05, *** p < 0.001, **** p < 0.0001 vs Day 0; one-way ANOVA followed by Dunnett’s multiple comparison test. b Representative immunoblots of estrogen-related receptor (ERR) α and γ protein levels during hiPSC-CM differentiation. α-Tubulin was used as a loading control. c Heatmap representing log 2 fold change [ERRα/γ knockout (KO)/wild-type control (WT)] of mRNA levels of genes involved in cardiac structural component, Ca 2+ handling function, and ion transport in two different KO cell lines (KO1, KO6). All changes were significant (Benjamini-Hochberg false discovery rate <0.05) except for SCN5A in KO1 ( p = 0.057). d Representative immunoblots of indicated protein levels in WT Control and ERRα/γ KO hiPSC-CMs. Total protein staining was shown as a loading control. e The mRNA levels of indicated genes determined by RT-qPCR in hiPSC-CMs following the infection of adenovirus expressing GFP or ERRγ (Ad-GFP or Ad-ERRγ). ** p < 0.01, *** p < 0.001, **** p < 0.0001, Ad-ERRγ vs Ad-GFP, two-tailed student’s t-test. PDK4 (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); COX6A2 (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); MDH1 and CKMT2 , (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); <t>TNNI3</t> (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); TNNI1 (Ad-GFP, n = 10 and Ad-ERRγ, n = 11). f The mRNA levels of indicated hiPSC-CM maturation markers determined by RT-qPCR in WT and ERRα/γ KO hiPSC-CMs derived from KO1 and KO6 with ( n = 15) or without ( n = 9) maturation cocktail treatment for 7 days. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, WT vs ERRα/γ KO hiPSC-CMs, two-way ANOVA followed by Tukey’s multiple comparisons test. All graphs in a , e , and f represent the means ± SEM. n denotes independent biological replicates. g Representative immunoblot images to show ACSL1 and TNNI3 protein expression levels in WT and ERRα/γ KO hiPSC-CMs with or without maturation cocktail. Total protein staining was used as a loading control.
Cardiac Troponin I (Ctni) Antibody, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cardiac troponin i (ctni) antibody/product/Merck KGaA
Average 90 stars, based on 1 article reviews
cardiac troponin i (ctni) antibody - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Biodesign International Inc ctni antibodies
a Real-time quantitative polymerase chain reaction (RT-qPCR)-determined levels of the designated mRNAs during human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) differentiation. Levels of indicated genes are shown normalized to RPLP0 levels at each timepoint. Day 0 and 2, n = 9; Day 4, 6, 8, and 15, n = 8. * p < 0.05, *** p < 0.001, **** p < 0.0001 vs Day 0; one-way ANOVA followed by Dunnett’s multiple comparison test. b Representative immunoblots of estrogen-related receptor (ERR) α and γ protein levels during hiPSC-CM differentiation. α-Tubulin was used as a loading control. c Heatmap representing log 2 fold change [ERRα/γ knockout (KO)/wild-type control (WT)] of mRNA levels of genes involved in cardiac structural component, Ca 2+ handling function, and ion transport in two different KO cell lines (KO1, KO6). All changes were significant (Benjamini-Hochberg false discovery rate <0.05) except for SCN5A in KO1 ( p = 0.057). d Representative immunoblots of indicated protein levels in WT Control and ERRα/γ KO hiPSC-CMs. Total protein staining was shown as a loading control. e The mRNA levels of indicated genes determined by RT-qPCR in hiPSC-CMs following the infection of adenovirus expressing GFP or ERRγ (Ad-GFP or Ad-ERRγ). ** p < 0.01, *** p < 0.001, **** p < 0.0001, Ad-ERRγ vs Ad-GFP, two-tailed student’s t-test. PDK4 (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); COX6A2 (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); MDH1 and CKMT2 , (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); <t>TNNI3</t> (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); TNNI1 (Ad-GFP, n = 10 and Ad-ERRγ, n = 11). f The mRNA levels of indicated hiPSC-CM maturation markers determined by RT-qPCR in WT and ERRα/γ KO hiPSC-CMs derived from KO1 and KO6 with ( n = 15) or without ( n = 9) maturation cocktail treatment for 7 days. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, WT vs ERRα/γ KO hiPSC-CMs, two-way ANOVA followed by Tukey’s multiple comparisons test. All graphs in a , e , and f represent the means ± SEM. n denotes independent biological replicates. g Representative immunoblot images to show ACSL1 and TNNI3 protein expression levels in WT and ERRα/γ KO hiPSC-CMs with or without maturation cocktail. Total protein staining was used as a loading control.
Ctni Antibodies, supplied by Biodesign International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ctni antibodies/product/Biodesign International Inc
Average 90 stars, based on 1 article reviews
ctni antibodies - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
HyTest monoclonal anti-ctni-antibody clones 19c7cc
a Real-time quantitative polymerase chain reaction (RT-qPCR)-determined levels of the designated mRNAs during human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) differentiation. Levels of indicated genes are shown normalized to RPLP0 levels at each timepoint. Day 0 and 2, n = 9; Day 4, 6, 8, and 15, n = 8. * p < 0.05, *** p < 0.001, **** p < 0.0001 vs Day 0; one-way ANOVA followed by Dunnett’s multiple comparison test. b Representative immunoblots of estrogen-related receptor (ERR) α and γ protein levels during hiPSC-CM differentiation. α-Tubulin was used as a loading control. c Heatmap representing log 2 fold change [ERRα/γ knockout (KO)/wild-type control (WT)] of mRNA levels of genes involved in cardiac structural component, Ca 2+ handling function, and ion transport in two different KO cell lines (KO1, KO6). All changes were significant (Benjamini-Hochberg false discovery rate <0.05) except for SCN5A in KO1 ( p = 0.057). d Representative immunoblots of indicated protein levels in WT Control and ERRα/γ KO hiPSC-CMs. Total protein staining was shown as a loading control. e The mRNA levels of indicated genes determined by RT-qPCR in hiPSC-CMs following the infection of adenovirus expressing GFP or ERRγ (Ad-GFP or Ad-ERRγ). ** p < 0.01, *** p < 0.001, **** p < 0.0001, Ad-ERRγ vs Ad-GFP, two-tailed student’s t-test. PDK4 (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); COX6A2 (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); MDH1 and CKMT2 , (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); <t>TNNI3</t> (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); TNNI1 (Ad-GFP, n = 10 and Ad-ERRγ, n = 11). f The mRNA levels of indicated hiPSC-CM maturation markers determined by RT-qPCR in WT and ERRα/γ KO hiPSC-CMs derived from KO1 and KO6 with ( n = 15) or without ( n = 9) maturation cocktail treatment for 7 days. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, WT vs ERRα/γ KO hiPSC-CMs, two-way ANOVA followed by Tukey’s multiple comparisons test. All graphs in a , e , and f represent the means ± SEM. n denotes independent biological replicates. g Representative immunoblot images to show ACSL1 and TNNI3 protein expression levels in WT and ERRα/γ KO hiPSC-CMs with or without maturation cocktail. Total protein staining was used as a loading control.
Monoclonal Anti Ctni Antibody Clones 19c7cc, supplied by HyTest, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal anti-ctni-antibody clones 19c7cc/product/HyTest
Average 90 stars, based on 1 article reviews
monoclonal anti-ctni-antibody clones 19c7cc - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Fapon Biotech ctni antibodies
a Real-time quantitative polymerase chain reaction (RT-qPCR)-determined levels of the designated mRNAs during human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) differentiation. Levels of indicated genes are shown normalized to RPLP0 levels at each timepoint. Day 0 and 2, n = 9; Day 4, 6, 8, and 15, n = 8. * p < 0.05, *** p < 0.001, **** p < 0.0001 vs Day 0; one-way ANOVA followed by Dunnett’s multiple comparison test. b Representative immunoblots of estrogen-related receptor (ERR) α and γ protein levels during hiPSC-CM differentiation. α-Tubulin was used as a loading control. c Heatmap representing log 2 fold change [ERRα/γ knockout (KO)/wild-type control (WT)] of mRNA levels of genes involved in cardiac structural component, Ca 2+ handling function, and ion transport in two different KO cell lines (KO1, KO6). All changes were significant (Benjamini-Hochberg false discovery rate <0.05) except for SCN5A in KO1 ( p = 0.057). d Representative immunoblots of indicated protein levels in WT Control and ERRα/γ KO hiPSC-CMs. Total protein staining was shown as a loading control. e The mRNA levels of indicated genes determined by RT-qPCR in hiPSC-CMs following the infection of adenovirus expressing GFP or ERRγ (Ad-GFP or Ad-ERRγ). ** p < 0.01, *** p < 0.001, **** p < 0.0001, Ad-ERRγ vs Ad-GFP, two-tailed student’s t-test. PDK4 (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); COX6A2 (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); MDH1 and CKMT2 , (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); <t>TNNI3</t> (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); TNNI1 (Ad-GFP, n = 10 and Ad-ERRγ, n = 11). f The mRNA levels of indicated hiPSC-CM maturation markers determined by RT-qPCR in WT and ERRα/γ KO hiPSC-CMs derived from KO1 and KO6 with ( n = 15) or without ( n = 9) maturation cocktail treatment for 7 days. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, WT vs ERRα/γ KO hiPSC-CMs, two-way ANOVA followed by Tukey’s multiple comparisons test. All graphs in a , e , and f represent the means ± SEM. n denotes independent biological replicates. g Representative immunoblot images to show ACSL1 and TNNI3 protein expression levels in WT and ERRα/γ KO hiPSC-CMs with or without maturation cocktail. Total protein staining was used as a loading control.
Ctni Antibodies, supplied by Fapon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ctni antibodies/product/Fapon Biotech
Average 90 stars, based on 1 article reviews
ctni antibodies - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
PhosphoSolutions ctni phosphoserine 23/24 antibody
a Real-time quantitative polymerase chain reaction (RT-qPCR)-determined levels of the designated mRNAs during human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) differentiation. Levels of indicated genes are shown normalized to RPLP0 levels at each timepoint. Day 0 and 2, n = 9; Day 4, 6, 8, and 15, n = 8. * p < 0.05, *** p < 0.001, **** p < 0.0001 vs Day 0; one-way ANOVA followed by Dunnett’s multiple comparison test. b Representative immunoblots of estrogen-related receptor (ERR) α and γ protein levels during hiPSC-CM differentiation. α-Tubulin was used as a loading control. c Heatmap representing log 2 fold change [ERRα/γ knockout (KO)/wild-type control (WT)] of mRNA levels of genes involved in cardiac structural component, Ca 2+ handling function, and ion transport in two different KO cell lines (KO1, KO6). All changes were significant (Benjamini-Hochberg false discovery rate <0.05) except for SCN5A in KO1 ( p = 0.057). d Representative immunoblots of indicated protein levels in WT Control and ERRα/γ KO hiPSC-CMs. Total protein staining was shown as a loading control. e The mRNA levels of indicated genes determined by RT-qPCR in hiPSC-CMs following the infection of adenovirus expressing GFP or ERRγ (Ad-GFP or Ad-ERRγ). ** p < 0.01, *** p < 0.001, **** p < 0.0001, Ad-ERRγ vs Ad-GFP, two-tailed student’s t-test. PDK4 (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); COX6A2 (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); MDH1 and CKMT2 , (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); <t>TNNI3</t> (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); TNNI1 (Ad-GFP, n = 10 and Ad-ERRγ, n = 11). f The mRNA levels of indicated hiPSC-CM maturation markers determined by RT-qPCR in WT and ERRα/γ KO hiPSC-CMs derived from KO1 and KO6 with ( n = 15) or without ( n = 9) maturation cocktail treatment for 7 days. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, WT vs ERRα/γ KO hiPSC-CMs, two-way ANOVA followed by Tukey’s multiple comparisons test. All graphs in a , e , and f represent the means ± SEM. n denotes independent biological replicates. g Representative immunoblot images to show ACSL1 and TNNI3 protein expression levels in WT and ERRα/γ KO hiPSC-CMs with or without maturation cocktail. Total protein staining was used as a loading control.
Ctni Phosphoserine 23/24 Antibody, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ctni phosphoserine 23/24 antibody/product/PhosphoSolutions
Average 90 stars, based on 1 article reviews
ctni phosphoserine 23/24 antibody - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Abbott Laboratories mouse monoclonal antibodies that recognize two epitopes in human hs-ctni
a Real-time quantitative polymerase chain reaction (RT-qPCR)-determined levels of the designated mRNAs during human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) differentiation. Levels of indicated genes are shown normalized to RPLP0 levels at each timepoint. Day 0 and 2, n = 9; Day 4, 6, 8, and 15, n = 8. * p < 0.05, *** p < 0.001, **** p < 0.0001 vs Day 0; one-way ANOVA followed by Dunnett’s multiple comparison test. b Representative immunoblots of estrogen-related receptor (ERR) α and γ protein levels during hiPSC-CM differentiation. α-Tubulin was used as a loading control. c Heatmap representing log 2 fold change [ERRα/γ knockout (KO)/wild-type control (WT)] of mRNA levels of genes involved in cardiac structural component, Ca 2+ handling function, and ion transport in two different KO cell lines (KO1, KO6). All changes were significant (Benjamini-Hochberg false discovery rate <0.05) except for SCN5A in KO1 ( p = 0.057). d Representative immunoblots of indicated protein levels in WT Control and ERRα/γ KO hiPSC-CMs. Total protein staining was shown as a loading control. e The mRNA levels of indicated genes determined by RT-qPCR in hiPSC-CMs following the infection of adenovirus expressing GFP or ERRγ (Ad-GFP or Ad-ERRγ). ** p < 0.01, *** p < 0.001, **** p < 0.0001, Ad-ERRγ vs Ad-GFP, two-tailed student’s t-test. PDK4 (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); COX6A2 (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); MDH1 and CKMT2 , (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); <t>TNNI3</t> (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); TNNI1 (Ad-GFP, n = 10 and Ad-ERRγ, n = 11). f The mRNA levels of indicated hiPSC-CM maturation markers determined by RT-qPCR in WT and ERRα/γ KO hiPSC-CMs derived from KO1 and KO6 with ( n = 15) or without ( n = 9) maturation cocktail treatment for 7 days. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, WT vs ERRα/γ KO hiPSC-CMs, two-way ANOVA followed by Tukey’s multiple comparisons test. All graphs in a , e , and f represent the means ± SEM. n denotes independent biological replicates. g Representative immunoblot images to show ACSL1 and TNNI3 protein expression levels in WT and ERRα/γ KO hiPSC-CMs with or without maturation cocktail. Total protein staining was used as a loading control.
Mouse Monoclonal Antibodies That Recognize Two Epitopes In Human Hs Ctni, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal antibodies that recognize two epitopes in human hs-ctni/product/Abbott Laboratories
Average 90 stars, based on 1 article reviews
mouse monoclonal antibodies that recognize two epitopes in human hs-ctni - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Immunofluorescent analysis indicates the expression of NKX2.5 and cTnI (green) in the hearts of rats with MI two and four weeks after PMSCs and HPL + PMSCs injection: ( A , B ): Sample micrographs of NKX2.5 and cTnI in an animal of each group. Quantification of the levels of NKX2.5 + and cTnI+ ( C and E ) and the number of Dil+/NKX2.5 + and Dil+/ cTnI+ ( D and F ) in the study groups. Stem cells stained with Dil dye (red) and nuclei with DAPI (blue). *** P < 0.001 vs. PMSCs 2 weeks; # < P < 0.05, ### P < 0.001 vs. HPL + PMSCs 2 weeks; &&& P < 0.01 vs. PMSCs; $$ P < 0.001, $$$ P < 0.001 vs. HPL + PMSCs. n = 3 in each group.

Journal: Scientific Reports

Article Title: Human platelet lysate combined with mesenchymal stem cells pretreated with platelet lysate improved cardiac function in rats with myocardial infarction

doi: 10.1038/s41598-024-79050-6

Figure Lengend Snippet: Immunofluorescent analysis indicates the expression of NKX2.5 and cTnI (green) in the hearts of rats with MI two and four weeks after PMSCs and HPL + PMSCs injection: ( A , B ): Sample micrographs of NKX2.5 and cTnI in an animal of each group. Quantification of the levels of NKX2.5 + and cTnI+ ( C and E ) and the number of Dil+/NKX2.5 + and Dil+/ cTnI+ ( D and F ) in the study groups. Stem cells stained with Dil dye (red) and nuclei with DAPI (blue). *** P < 0.001 vs. PMSCs 2 weeks; # < P < 0.05, ### P < 0.001 vs. HPL + PMSCs 2 weeks; &&& P < 0.01 vs. PMSCs; $$ P < 0.001, $$$ P < 0.001 vs. HPL + PMSCs. n = 3 in each group.

Article Snippet: Rabbit polyclonal primary antibody for NKX2 (No: orb540657), rabbit polyclonal antibody for cTnI (No: orb304638), and goat anti-rabbit IgG (H + L) antibody (FITC) (No orb688925) were purchased from Biorbyt, United Kingdom.

Techniques: Expressing, Injection, Staining

a Real-time quantitative polymerase chain reaction (RT-qPCR)-determined levels of the designated mRNAs during human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) differentiation. Levels of indicated genes are shown normalized to RPLP0 levels at each timepoint. Day 0 and 2, n = 9; Day 4, 6, 8, and 15, n = 8. * p < 0.05, *** p < 0.001, **** p < 0.0001 vs Day 0; one-way ANOVA followed by Dunnett’s multiple comparison test. b Representative immunoblots of estrogen-related receptor (ERR) α and γ protein levels during hiPSC-CM differentiation. α-Tubulin was used as a loading control. c Heatmap representing log 2 fold change [ERRα/γ knockout (KO)/wild-type control (WT)] of mRNA levels of genes involved in cardiac structural component, Ca 2+ handling function, and ion transport in two different KO cell lines (KO1, KO6). All changes were significant (Benjamini-Hochberg false discovery rate <0.05) except for SCN5A in KO1 ( p = 0.057). d Representative immunoblots of indicated protein levels in WT Control and ERRα/γ KO hiPSC-CMs. Total protein staining was shown as a loading control. e The mRNA levels of indicated genes determined by RT-qPCR in hiPSC-CMs following the infection of adenovirus expressing GFP or ERRγ (Ad-GFP or Ad-ERRγ). ** p < 0.01, *** p < 0.001, **** p < 0.0001, Ad-ERRγ vs Ad-GFP, two-tailed student’s t-test. PDK4 (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); COX6A2 (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); MDH1 and CKMT2 , (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); TNNI3 (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); TNNI1 (Ad-GFP, n = 10 and Ad-ERRγ, n = 11). f The mRNA levels of indicated hiPSC-CM maturation markers determined by RT-qPCR in WT and ERRα/γ KO hiPSC-CMs derived from KO1 and KO6 with ( n = 15) or without ( n = 9) maturation cocktail treatment for 7 days. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, WT vs ERRα/γ KO hiPSC-CMs, two-way ANOVA followed by Tukey’s multiple comparisons test. All graphs in a , e , and f represent the means ± SEM. n denotes independent biological replicates. g Representative immunoblot images to show ACSL1 and TNNI3 protein expression levels in WT and ERRα/γ KO hiPSC-CMs with or without maturation cocktail. Total protein staining was used as a loading control.

Journal: Nature Communications

Article Title: The nuclear receptor ERR cooperates with the cardiogenic factor GATA4 to orchestrate cardiomyocyte maturation

doi: 10.1038/s41467-022-29733-3

Figure Lengend Snippet: a Real-time quantitative polymerase chain reaction (RT-qPCR)-determined levels of the designated mRNAs during human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) differentiation. Levels of indicated genes are shown normalized to RPLP0 levels at each timepoint. Day 0 and 2, n = 9; Day 4, 6, 8, and 15, n = 8. * p < 0.05, *** p < 0.001, **** p < 0.0001 vs Day 0; one-way ANOVA followed by Dunnett’s multiple comparison test. b Representative immunoblots of estrogen-related receptor (ERR) α and γ protein levels during hiPSC-CM differentiation. α-Tubulin was used as a loading control. c Heatmap representing log 2 fold change [ERRα/γ knockout (KO)/wild-type control (WT)] of mRNA levels of genes involved in cardiac structural component, Ca 2+ handling function, and ion transport in two different KO cell lines (KO1, KO6). All changes were significant (Benjamini-Hochberg false discovery rate <0.05) except for SCN5A in KO1 ( p = 0.057). d Representative immunoblots of indicated protein levels in WT Control and ERRα/γ KO hiPSC-CMs. Total protein staining was shown as a loading control. e The mRNA levels of indicated genes determined by RT-qPCR in hiPSC-CMs following the infection of adenovirus expressing GFP or ERRγ (Ad-GFP or Ad-ERRγ). ** p < 0.01, *** p < 0.001, **** p < 0.0001, Ad-ERRγ vs Ad-GFP, two-tailed student’s t-test. PDK4 (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); COX6A2 (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); MDH1 and CKMT2 , (Ad-GFP, n = 7 and Ad-ERRγ, n = 8); TNNI3 (Ad-GFP, n = 14 and Ad-ERRγ, n = 15); TNNI1 (Ad-GFP, n = 10 and Ad-ERRγ, n = 11). f The mRNA levels of indicated hiPSC-CM maturation markers determined by RT-qPCR in WT and ERRα/γ KO hiPSC-CMs derived from KO1 and KO6 with ( n = 15) or without ( n = 9) maturation cocktail treatment for 7 days. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, WT vs ERRα/γ KO hiPSC-CMs, two-way ANOVA followed by Tukey’s multiple comparisons test. All graphs in a , e , and f represent the means ± SEM. n denotes independent biological replicates. g Representative immunoblot images to show ACSL1 and TNNI3 protein expression levels in WT and ERRα/γ KO hiPSC-CMs with or without maturation cocktail. Total protein staining was used as a loading control.

Article Snippet: The following antibodies were used: ERRα; SMYD1; VDAC; ACSL3; TNNI3 (Abcam catalog and clone #s: ab76228; EPR46Y, ab181372; EPR13574(B)-30, ab15895, ab151959, and ab47003 respectively); His tag; α-tubulin; ACSL1 (Cell Signaling Technology catalog and clone #s: 12698S; D3I1O, 3873; DM1A, and 9189; D2H5 respectively); HA tag and MYL2 (Proteintech catalog #s 51064-2-AP and 10906-1-AP); α-Actinin, FLAG M2, TNNI1, ACTB, and PGC-1α (Sigma-Aldrich catalog and clone #s: A7732-100UL; EA-53, F1804-50UG; M2, AV42117-100UL, A5316; AC-74, and ST1202; 4C1.3); GATA4 and MYBPC3 (SANTA CRUZ BIOTECHNOLOGY catalog and clone #s, sc-25310; G-4, and sc-137180; E-7).

Techniques: Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Derivative Assay, Comparison, Western Blot, Control, Knock-Out, Staining, Infection, Expressing, Two Tailed Test

a Venn diagram indicates the overlapped peaks from published GATA4 chromatin immunoprecipitation sequencing (ChIP-seq; GSE85631) and ERRγ ChIP-seq (GSE113784) datasets generated from human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). GATA4 and ERRγ-shared peaks (ERRγ + GATA4) are presented by orange-colored region. p values were calculated using Fisher’s exact test. b Pie chart represents the overlapped sites from published GATA4 ChIP-seq, cardiac super-enhancers (SEs; GSE85631), and ERRγ ChIP-seq (GSE113784) datasets in hiPSC-CMs. The 45 SEs where ERRγ and GATA4 peaks are colocalized within 200 base pairs are highlighted with yellow. c Top 20 transcription factors that significantly overlapped with ERRγ + GATA4 and ERRγ-GATA4 are plotted. ESRRA was ranked in the top 30 in the ERRγ + GATA4 analysis. Y axis represents the similarity (GIGGLE score) between published datasets and each peak set. d Bars indicate enrichment score for Gene Ontology (GO) Biological Process and GO Cellular Component terms significantly enriched in ERRγ + GATA4 targets. e Representative genomic browser tracks of TNNI3 , MYBPC3 , and MYH6-7 regions. f Bar graphs represent mRNA expression levels of a subset of ERRγ + GATA4 and ERRγ targets in Negative Control (NC) ( n = 9) and siGATA4#1 ( n = 7) or siGATA4#2 ( n = 7) transfected hiPSC-CMs. * p < 0.05, ** p < 0.01, **** p < 0.0001, one-way ANOVA followed by Dunnett’s multiple comparisons test. All bars represent the means ± SEM. n denotes independent biological replicates.

Journal: Nature Communications

Article Title: The nuclear receptor ERR cooperates with the cardiogenic factor GATA4 to orchestrate cardiomyocyte maturation

doi: 10.1038/s41467-022-29733-3

Figure Lengend Snippet: a Venn diagram indicates the overlapped peaks from published GATA4 chromatin immunoprecipitation sequencing (ChIP-seq; GSE85631) and ERRγ ChIP-seq (GSE113784) datasets generated from human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). GATA4 and ERRγ-shared peaks (ERRγ + GATA4) are presented by orange-colored region. p values were calculated using Fisher’s exact test. b Pie chart represents the overlapped sites from published GATA4 ChIP-seq, cardiac super-enhancers (SEs; GSE85631), and ERRγ ChIP-seq (GSE113784) datasets in hiPSC-CMs. The 45 SEs where ERRγ and GATA4 peaks are colocalized within 200 base pairs are highlighted with yellow. c Top 20 transcription factors that significantly overlapped with ERRγ + GATA4 and ERRγ-GATA4 are plotted. ESRRA was ranked in the top 30 in the ERRγ + GATA4 analysis. Y axis represents the similarity (GIGGLE score) between published datasets and each peak set. d Bars indicate enrichment score for Gene Ontology (GO) Biological Process and GO Cellular Component terms significantly enriched in ERRγ + GATA4 targets. e Representative genomic browser tracks of TNNI3 , MYBPC3 , and MYH6-7 regions. f Bar graphs represent mRNA expression levels of a subset of ERRγ + GATA4 and ERRγ targets in Negative Control (NC) ( n = 9) and siGATA4#1 ( n = 7) or siGATA4#2 ( n = 7) transfected hiPSC-CMs. * p < 0.05, ** p < 0.01, **** p < 0.0001, one-way ANOVA followed by Dunnett’s multiple comparisons test. All bars represent the means ± SEM. n denotes independent biological replicates.

Article Snippet: The following antibodies were used: ERRα; SMYD1; VDAC; ACSL3; TNNI3 (Abcam catalog and clone #s: ab76228; EPR46Y, ab181372; EPR13574(B)-30, ab15895, ab151959, and ab47003 respectively); His tag; α-tubulin; ACSL1 (Cell Signaling Technology catalog and clone #s: 12698S; D3I1O, 3873; DM1A, and 9189; D2H5 respectively); HA tag and MYL2 (Proteintech catalog #s 51064-2-AP and 10906-1-AP); α-Actinin, FLAG M2, TNNI1, ACTB, and PGC-1α (Sigma-Aldrich catalog and clone #s: A7732-100UL; EA-53, F1804-50UG; M2, AV42117-100UL, A5316; AC-74, and ST1202; 4C1.3); GATA4 and MYBPC3 (SANTA CRUZ BIOTECHNOLOGY catalog and clone #s, sc-25310; G-4, and sc-137180; E-7).

Techniques: ChIP-sequencing, Generated, Derivative Assay, Expressing, Negative Control, Transfection

a mRNA expression level of TNNI3 in wild-type (WT) control ( n = 6) and ERRα/γ knockout (KO) line 1 or 6 ( n = 3) human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) following the overexpression of PGC-1α and/or GATA4 (Ad-PGC-1α and/or Ad-GATA4). ** p < 0.01, **** p < 0.0001, two-way ANOVA followed by Tukey’s multiple comparisons test. b Representative immunoblot images to show hemagglutinin (HA)-tagged GATA4, His-tagged PGC-1α, TNNI3, and TNNI1. c Levels of HA-tagged GATA4 occupation on the indicated targets in WT ( n = 5 or n = 4 for TNNI3 and POU5F1 ) and ERRα/γ KO hiPSC-CMs ( n = 5). * p < 0.05 vs WT, two-tailed student’s t -test. MYH6 -7 denotes the enhancer site of MYH6-7 cluster. d Bar graphs represent relative light units (RLU) derived from TNNI3 promoter-luciferase reporter ( TNNI3 -luc) with overexpression of ERRγ, GATA4, and PGC-1α in H9c2 myoblast. of TNNI3 -luc. n = 12, **** p < 0.0001, one-way ANOVA followed by Tukey multiple comparisons test. e Bar graphs represent the RLU derived from TNNI3 -luc or COX6A2 luciferase reporter ( COX6A2 -luc) in H9c2 myoblasts transduced with CRISPR/Cas9 and non-targeting control (NTC) guide RNA (gRNA) or gRNA targeting ERRα and γ (ERRα/γ KD). n = 12 for NTC in COX6A2 -luc or n = 9 for others. *** p < 0.001, **** p < 0.0001, two-way ANOVA followed by Tukey’s multiple comparisons test. f Schematic of TNNI3 promoter with putative ERR response elements (ERRE) and GATA binding sites. g WT ( n = 25), ERRE-deleted ( n = 12) or GATA binding sites-deleted ( n = 16) - TNNI3 -luc were assessed with overexpression of ERRγ and/or GATA4 in H9c2 myoblasts. * p < 0.05, **** p < 0.0001, two-way ANOVA followed by Tukey’s multiple comparisons test. h Bar graphs represents RLU derived from TNNI3 -luc with overexpression of ERRγ ( n = 15), GATA4 WT ( n = 15), C-teriminal zinc finger deleted GATA4 (C-zincΔ, n = 12), N-terminal zinc finger deleted GATA4 (N-zincΔ, n = 6), the combination of ERRγ and WT (n = 15) or each GATA4 mutant (C-zincΔ, n = 12; N-zincΔ, n = 6) in H9c2 myoblasts. * p < 0.05, **** p < 0.0001, one-way ANOVA followed by Tukey’s multiple comparisons test. i Bar graphs represents RLU derived from control reporter (empty-luc; n = 8 for ERRγ + PGC-1α or n = 9 for others) and MYH6-7 enhancer-luc ( n = 9) with overexpressed indicated factors in AC16 cells. **** p < 0.0001, two-way ANOVA followed by Tukey’s multiple comparisons test. All bars represent the means ± SEM. n denotes independent biological replicates.

Journal: Nature Communications

Article Title: The nuclear receptor ERR cooperates with the cardiogenic factor GATA4 to orchestrate cardiomyocyte maturation

doi: 10.1038/s41467-022-29733-3

Figure Lengend Snippet: a mRNA expression level of TNNI3 in wild-type (WT) control ( n = 6) and ERRα/γ knockout (KO) line 1 or 6 ( n = 3) human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) following the overexpression of PGC-1α and/or GATA4 (Ad-PGC-1α and/or Ad-GATA4). ** p < 0.01, **** p < 0.0001, two-way ANOVA followed by Tukey’s multiple comparisons test. b Representative immunoblot images to show hemagglutinin (HA)-tagged GATA4, His-tagged PGC-1α, TNNI3, and TNNI1. c Levels of HA-tagged GATA4 occupation on the indicated targets in WT ( n = 5 or n = 4 for TNNI3 and POU5F1 ) and ERRα/γ KO hiPSC-CMs ( n = 5). * p < 0.05 vs WT, two-tailed student’s t -test. MYH6 -7 denotes the enhancer site of MYH6-7 cluster. d Bar graphs represent relative light units (RLU) derived from TNNI3 promoter-luciferase reporter ( TNNI3 -luc) with overexpression of ERRγ, GATA4, and PGC-1α in H9c2 myoblast. of TNNI3 -luc. n = 12, **** p < 0.0001, one-way ANOVA followed by Tukey multiple comparisons test. e Bar graphs represent the RLU derived from TNNI3 -luc or COX6A2 luciferase reporter ( COX6A2 -luc) in H9c2 myoblasts transduced with CRISPR/Cas9 and non-targeting control (NTC) guide RNA (gRNA) or gRNA targeting ERRα and γ (ERRα/γ KD). n = 12 for NTC in COX6A2 -luc or n = 9 for others. *** p < 0.001, **** p < 0.0001, two-way ANOVA followed by Tukey’s multiple comparisons test. f Schematic of TNNI3 promoter with putative ERR response elements (ERRE) and GATA binding sites. g WT ( n = 25), ERRE-deleted ( n = 12) or GATA binding sites-deleted ( n = 16) - TNNI3 -luc were assessed with overexpression of ERRγ and/or GATA4 in H9c2 myoblasts. * p < 0.05, **** p < 0.0001, two-way ANOVA followed by Tukey’s multiple comparisons test. h Bar graphs represents RLU derived from TNNI3 -luc with overexpression of ERRγ ( n = 15), GATA4 WT ( n = 15), C-teriminal zinc finger deleted GATA4 (C-zincΔ, n = 12), N-terminal zinc finger deleted GATA4 (N-zincΔ, n = 6), the combination of ERRγ and WT (n = 15) or each GATA4 mutant (C-zincΔ, n = 12; N-zincΔ, n = 6) in H9c2 myoblasts. * p < 0.05, **** p < 0.0001, one-way ANOVA followed by Tukey’s multiple comparisons test. i Bar graphs represents RLU derived from control reporter (empty-luc; n = 8 for ERRγ + PGC-1α or n = 9 for others) and MYH6-7 enhancer-luc ( n = 9) with overexpressed indicated factors in AC16 cells. **** p < 0.0001, two-way ANOVA followed by Tukey’s multiple comparisons test. All bars represent the means ± SEM. n denotes independent biological replicates.

Article Snippet: The following antibodies were used: ERRα; SMYD1; VDAC; ACSL3; TNNI3 (Abcam catalog and clone #s: ab76228; EPR46Y, ab181372; EPR13574(B)-30, ab15895, ab151959, and ab47003 respectively); His tag; α-tubulin; ACSL1 (Cell Signaling Technology catalog and clone #s: 12698S; D3I1O, 3873; DM1A, and 9189; D2H5 respectively); HA tag and MYL2 (Proteintech catalog #s 51064-2-AP and 10906-1-AP); α-Actinin, FLAG M2, TNNI1, ACTB, and PGC-1α (Sigma-Aldrich catalog and clone #s: A7732-100UL; EA-53, F1804-50UG; M2, AV42117-100UL, A5316; AC-74, and ST1202; 4C1.3); GATA4 and MYBPC3 (SANTA CRUZ BIOTECHNOLOGY catalog and clone #s, sc-25310; G-4, and sc-137180; E-7).

Techniques: Expressing, Control, Knock-Out, Derivative Assay, Over Expression, Western Blot, Two Tailed Test, Luciferase, Transduction, CRISPR, Binding Assay, Mutagenesis

a Bar graphs represent the relative light unit (RLU) from pG5luc construct. ERRγ-Gal4, GATA4/PGC-1α/ERRγ-Gal4, GATA4/ERRγ-Gal4, and PGC-1α/ERRγ-Gal4, n = 18; Gal4, n = 17; PGC-1α/Gal4, n = 16; GATA4/Gal4, n = 15; GATA4/PGC-1α/Gal4, PGC-1α m/ERRγ-Gal4, PGC-1α m/ERRγ-Gal4, n = 9; PGC-1α m/Gal4, n = 6, **** p < 0.0001, one-way ANOVA followed by Tukey’s multiple comparisons test. b Bar graphs represent the mRNA levels of indicated genes in wild-type control (WT, n = 8) and PGC-1α knockdown (KD, n = 8) human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 vs WT, two-tailed Student’s t-test. c Levels of ERRγ occupation on the indicated targets in WT (n = 6 for MYH6 -7 and NPPA-NPPB , n = 8 for POU5F1 , n = 5 for others), PGC-1α KD ( n = 8 for TNNI3 , TNNC1 , FABP3 , and CPT1B , n = 6 for MYBPC3 and POU5F1 , n = 7 for MYH6 -7, NPPA-NPPB , and ATP5B ), and ERRα/γ knockout (KO) hiPSC-CMs ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001 vs WT, one-way ANOVA followed by Dunnett’s multiple comparisons test. Stem cell enhancer region on POU5F1 was used as a negative control. MYH6 -7 and NPPA-NPPB denote the distal enhancer sites upstream of each gene cluster. d Representative immunoblot images to show the interaction between FLAG-tagged ERRγ and endogenous GATA4 in FLAG-ERRγ overexpressed hiPSC-CMs. e Schematic to indicate reported naturally occurring GATA4 mutations. NLS denotes nuclear localization signal. ERRγ-Gal4 experiment was performed with PGC-1α and GATA4 natural mutants. Bar graphs indicate RLU from pG5luc construct in AD-293 cells. ** p < 0.01, *** p < 0.001, vs ERRγ, PGC-1α, and WT GATA4 transfected group, one-way ANOVA followed by Tukey multiple comparisons test. n = 6. f TNNI3 -luc reporter experiment with overexpression of ERRγ and GATA4 WT or GATA4 G296S in H9c2 myoblast. Bar graphs represent RLU of TNNI3 -luc. n = 9, **** p < 0.0001, one-way ANOVA followed by Tukey multiple comparisons test. g Venn diagram showing significant overlap (using Fisher’s exact test) between RNA-seq datasets generated in G296S GATA4 hiPSC-CMs (GSE85631) and ERRα/γ KO hiPSC-CMs (GSE165963). Bar graphs represent enrichment score for significantly enriched Gene Ontology (GO) Biological Process and GO Cellular Component with the commonly downregulated genes. All bars in a , b , c , e , and f represent the means ± SEM. n denotes independent biological replicates.

Journal: Nature Communications

Article Title: The nuclear receptor ERR cooperates with the cardiogenic factor GATA4 to orchestrate cardiomyocyte maturation

doi: 10.1038/s41467-022-29733-3

Figure Lengend Snippet: a Bar graphs represent the relative light unit (RLU) from pG5luc construct. ERRγ-Gal4, GATA4/PGC-1α/ERRγ-Gal4, GATA4/ERRγ-Gal4, and PGC-1α/ERRγ-Gal4, n = 18; Gal4, n = 17; PGC-1α/Gal4, n = 16; GATA4/Gal4, n = 15; GATA4/PGC-1α/Gal4, PGC-1α m/ERRγ-Gal4, PGC-1α m/ERRγ-Gal4, n = 9; PGC-1α m/Gal4, n = 6, **** p < 0.0001, one-way ANOVA followed by Tukey’s multiple comparisons test. b Bar graphs represent the mRNA levels of indicated genes in wild-type control (WT, n = 8) and PGC-1α knockdown (KD, n = 8) human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 vs WT, two-tailed Student’s t-test. c Levels of ERRγ occupation on the indicated targets in WT (n = 6 for MYH6 -7 and NPPA-NPPB , n = 8 for POU5F1 , n = 5 for others), PGC-1α KD ( n = 8 for TNNI3 , TNNC1 , FABP3 , and CPT1B , n = 6 for MYBPC3 and POU5F1 , n = 7 for MYH6 -7, NPPA-NPPB , and ATP5B ), and ERRα/γ knockout (KO) hiPSC-CMs ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001 vs WT, one-way ANOVA followed by Dunnett’s multiple comparisons test. Stem cell enhancer region on POU5F1 was used as a negative control. MYH6 -7 and NPPA-NPPB denote the distal enhancer sites upstream of each gene cluster. d Representative immunoblot images to show the interaction between FLAG-tagged ERRγ and endogenous GATA4 in FLAG-ERRγ overexpressed hiPSC-CMs. e Schematic to indicate reported naturally occurring GATA4 mutations. NLS denotes nuclear localization signal. ERRγ-Gal4 experiment was performed with PGC-1α and GATA4 natural mutants. Bar graphs indicate RLU from pG5luc construct in AD-293 cells. ** p < 0.01, *** p < 0.001, vs ERRγ, PGC-1α, and WT GATA4 transfected group, one-way ANOVA followed by Tukey multiple comparisons test. n = 6. f TNNI3 -luc reporter experiment with overexpression of ERRγ and GATA4 WT or GATA4 G296S in H9c2 myoblast. Bar graphs represent RLU of TNNI3 -luc. n = 9, **** p < 0.0001, one-way ANOVA followed by Tukey multiple comparisons test. g Venn diagram showing significant overlap (using Fisher’s exact test) between RNA-seq datasets generated in G296S GATA4 hiPSC-CMs (GSE85631) and ERRα/γ KO hiPSC-CMs (GSE165963). Bar graphs represent enrichment score for significantly enriched Gene Ontology (GO) Biological Process and GO Cellular Component with the commonly downregulated genes. All bars in a , b , c , e , and f represent the means ± SEM. n denotes independent biological replicates.

Article Snippet: The following antibodies were used: ERRα; SMYD1; VDAC; ACSL3; TNNI3 (Abcam catalog and clone #s: ab76228; EPR46Y, ab181372; EPR13574(B)-30, ab15895, ab151959, and ab47003 respectively); His tag; α-tubulin; ACSL1 (Cell Signaling Technology catalog and clone #s: 12698S; D3I1O, 3873; DM1A, and 9189; D2H5 respectively); HA tag and MYL2 (Proteintech catalog #s 51064-2-AP and 10906-1-AP); α-Actinin, FLAG M2, TNNI1, ACTB, and PGC-1α (Sigma-Aldrich catalog and clone #s: A7732-100UL; EA-53, F1804-50UG; M2, AV42117-100UL, A5316; AC-74, and ST1202; 4C1.3); GATA4 and MYBPC3 (SANTA CRUZ BIOTECHNOLOGY catalog and clone #s, sc-25310; G-4, and sc-137180; E-7).

Techniques: Construct, Control, Knockdown, Derivative Assay, Two Tailed Test, Knock-Out, Negative Control, Western Blot, Transfection, Over Expression, RNA Sequencing, Generated